MICHELE REDELL

Concepts (298)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with MICHELE REDELL's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that MICHELE REDELL has written about over time.
STAT3 Transcription Factor, 8 publications between 2005 and 2021, average publication date September 2012. STAT5 Transcription Factor, 3 publications between 2005 and 2021, average publication date February 2013. Granulocyte Colony-Stimulating Factor, 4 publications between 2007 and 2021, average publication date April 2013. Gene Rearrangement, 3 publications between 2014 and 2016, average publication date November 2014. Enzyme Inhibitors, 2 publications between 2014 and 2016, average publication date April 2015. Methyltransferases, 2 publications between 2014 and 2016, average publication date April 2015. Cysteine-Rich Protein 61, 1 publications between 2015 and 2015, average publication date May 2015. Intracellular Signaling Peptides and Proteins, 1 publications between 2015 and 2015, average publication date May 2015. Mitoxantrone, 1 publications between 2015 and 2015, average publication date May 2015. Protein-Tyrosine Kinases, 1 publications between 2015 and 2015, average publication date May 2015. Apoptosis, 8 publications between 2007 and 2020, average publication date September 2015. Antineoplastic Agents, 7 publications between 2005 and 2023, average publication date February 2017. Leukemia, Myeloid, Acute, 15 publications between 2011 and 2024, average publication date July 2017. Drug Resistance, Neoplasm, 2 publications between 2015 and 2021, average publication date May 2018. Myeloid-Lymphoid Leukemia Protein, 3 publications between 2014 and 2024, average publication date May 2018. Transcriptome, 3 publications between 2018 and 2021, average publication date April 2019. MAP Kinase Signaling System, 1 publications between 2021 and 2021, average publication date May 2021. Tumor Suppressor Proteins, 1 publications between 2021 and 2021, average publication date May 2021. Leukemia, Myelogenous, Chronic, BCR-ABL Positive, 2 publications between 2019 and 2023, average publication date September 2021. Interleukin-10, 1 publications between 2022 and 2022, average publication date July 2022.

To see the data from this visualization as text, click here.
REDELL's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (298)
Explore
_
Co-Authors (43)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_